BioVie Inc. Employee Benefits and Share-based Compensation
BioVie Inc. (BIVI) reported Employee Benefits and Share-based Compensation of $893.48 thousand for the 12-month period ending 2018-06-30, per its 10-K filed 2018-10-05.
Discontinued › Notes › Compensation Related Costs
us-gaap:EmployeeBenefitsAndShareBasedCompensation · last filed 2018-10-05
- BioVie Inc. employee benefits and share-based compensation for the quarter ending 2018-06-30 was $82.28K, a 43.93% increase year-over-year.
- BioVie Inc. employee benefits and share-based compensation for the quarter ending 2018-03-31 was $771.43K, a 5126.85% increase year-over-year.
- BioVie Inc. employee benefits and share-based compensation for the quarter ending 2017-12-31 was $27.02K, a 139.61% increase year-over-year.
- BioVie Inc. employee benefits and share-based compensation for the quarter ending 2017-09-30 was $12.75K, a 44.11% increase year-over-year.
- BioVie Inc. employee benefits and share-based compensation for fiscal 2018 was $893.48K, a 870.63% increase from fiscal 2017.
- BioVie Inc. employee benefits and share-based compensation for fiscal 2017 was $92.05K, a 1068.91% increase from fiscal 2016.
- BioVie Inc. employee benefits and share-based compensation for fiscal 2016 was $7.88K.
| Period end | Employee Benefits and Share-based Compensation 3 month | Employee Benefits and Share-based Compensation 6 month | Employee Benefits and Share-based Compensation 9 month | Employee Benefits and Share-based Compensation 12 month |
|---|---|---|---|---|
| 2018-06-30 | $82.28K derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-05 | $853.71K derived: sum of 2 quarters · filed 2018-10-05 | $880.73K derived: sum of 3 quarters · filed 2018-10-05 | $893.48K 10-K · filed 2018-10-05 |
| 2018-03-31 | $771.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-14 | $798.45K derived: sum of 2 quarters · filed 2018-05-14 | $811.20K 10-Q · filed 2018-05-14 | $868.37K derived: sum of 4 quarters · filed 2018-10-05 |
| 2017-12-31 | $27.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-14 | $39.77K 10-Q · filed 2018-02-14 | $96.94K derived: sum of 3 quarters · filed 2018-10-05 | $111.70K derived: sum of 4 quarters · filed 2018-10-05 |
| 2017-09-30 | $12.75K 10-Q · filed 2017-11-08 | $69.92K derived: sum of 2 quarters · filed 2018-10-05 | $84.68K derived: sum of 3 quarters · filed 2018-10-05 | $95.95K derived: sum of 4 quarters · filed 2018-10-05 |
| 2017-06-30 | $57.17K derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-05 | $71.93K derived: sum of 2 quarters · filed 2018-10-05 | $83.20K derived: sum of 3 quarters · filed 2018-10-05 | $92.05K 10-K · filed 2018-10-05 |
| 2017-03-31 | $14.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-14 | $26.04K derived: sum of 2 quarters · filed 2018-05-14 | $34.88K 10-Q · filed 2018-05-14 | |
| 2016-12-31 | $11.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-14 | $20.13K 10-Q · filed 2018-02-14 | ||
| 2016-09-30 | $8.85K 10-Q · filed 2017-11-08 | |||
| 2016-06-30 | $7.88K 10-K · filed 2017-08-24 | |||
| 2015-09-30 | $0.00 10-Q/A · filed 2017-01-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |